Difference between revisions of "PARKINSONS PLUS-MULTISYSTEM ATROPHY (MSA)"
(Imported from text file) |
(Imported from text file) |
||
Line 1: | Line 1: | ||
===== [[Summary Article|'''SUMMARY''']] ===== | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
1. Two types: MSA-Parkinsonian type (MSA-P) & MSA-cerebellar type (MSA-C). | 1. Two types: MSA-Parkinsonian type (MSA-P) & MSA-cerebellar type (MSA-C). | ||
<br/> | |||
<br/>2. MSA-P is further sub-divided into 3 syndromes: Shy-Drager (Parkinsons features with autonomic dysfunction), Olivo-ponto-cerebellar (Parkinsons features with ataxia & dysarthria), striatonigral degeneration (Parkinsons features with dystonia). | <br/>2. MSA-P is further sub-divided into 3 syndromes: Shy-Drager (Parkinsons features with autonomic dysfunction), Olivo-ponto-cerebellar (Parkinsons features with ataxia & dysarthria), striatonigral degeneration (Parkinsons features with dystonia). | ||
Latest revision as of 11:07, 20 March 2023
SUMMARY
1. Two types: MSA-Parkinsonian type (MSA-P) & MSA-cerebellar type (MSA-C).
2. MSA-P is further sub-divided into 3 syndromes: Shy-Drager (Parkinsons features with autonomic dysfunction), Olivo-ponto-cerebellar (Parkinsons features with ataxia & dysarthria), striatonigral degeneration (Parkinsons features with dystonia).
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].